Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CASA
3251
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $265K | ﹤0.01% |
+20,220
| New | +$290K |
|
|
LEAF
3252
DELISTED
Leaf Group Ltd.
LEAF
| $265K | ﹤0.01% |
38,736
-14,505
| -27% | -$124K |
|
|
KYNB
3253
Kyntra Bio
KYNB
$32.3M
| $264K | ﹤0.01% |
228
-4,036
| -95% | -$4.54M |
|
3254
Chefs' Warehouse
CHEF
$4.63B
| $263K | ﹤0.01% |
8,216
-36,636
| -82% | -$1.27M |
|
3255
SFL Corp
SFL
$1.63B
| $263K | ﹤0.01% |
+24,945
| New | +$312K |
|
|
GAU
3256
Galiano Gold
GAU
$633M
| $262K | ﹤0.01% |
409,888
+133,005
| +48% | +$97.2K |
|
3257
S&T Bancorp
STBA
$1.77B
| $262K | ﹤0.01% |
6,931
+2,216
| +47% | +$89.3K |
|
|
LLL
3258
DELISTED
L3 Technologies, Inc.
LLL
| $261K | ﹤0.01% |
1,502
-282,204
| -99% | -$54.3M |
|
3259
HealthStream
HSTM
$842M
| $260K | ﹤0.01% |
10,750
+2,282
| +27% | +$59.2K |
|
|
PZN
3260
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $259K | ﹤0.01% |
29,980
-21,356
| -42% | -$207K |
|
3261
Skywest
SKYW
$3.95B
| $258K | ﹤0.01% |
5,809
-12,724
| -69% | -$657K |
|
3262
CALL
AMC Entertainment Holdings
AMC
$2.38B
| $257K | ﹤0.01% |
2,090
| – | – |
|
3263
KNOT Offshore Partners
KNOP
$369M
| $257K | ﹤0.01% |
+14,358
| New | +$290K |
|
|
SPNS
3264
DELISTED
Sapiens International
SPNS
| $257K | ﹤0.01% |
23,343
-70,865
| -75% | -$814K |
|
3265
CALL
Take-Two Interactive
TTWO
$43.7B
| $257K | ﹤0.01% |
2,500
| – | – |
|
3266
West Bancorporation
WTBA
$485M
| $257K | ﹤0.01% |
13,452
-7,445
| -36% | -$157K |
|
3267
TETRA Technologies
TTI
$1B
| $256K | ﹤0.01% |
152,292
-434,711
| -74% | -$1.21M |
|
3268
Urban One Class D
UONEK
$20.5M
| $256K | ﹤0.01% |
15,901
-3,997
| -20% | -$84.2K |
|
|
MSVB
3269
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
| $256K | ﹤0.01% |
22,104
-9,853
| -31% | -$120K |
|
|
NBEV
3270
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $256K | ﹤0.01% |
+49,248
| New | +$258K |
|
3271
Entegris
ENTG
$21.1B
| $255K | ﹤0.01% |
9,155
-115,471
| -93% | -$3.12M |
|
|
EIGR
3272
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $255K | ﹤0.01% |
+836
| New | +$270K |
|
|
LION
3273
DELISTED
Fidelity Southern Corporation
LION
| $255K | ﹤0.01% |
+9,806
| New | +$231K |
|
3274
Bionano Genomics
BNGO
$14.4M
| $254K | ﹤0.01% |
+81
| New | +$323K |
|
3275
Columbia Financial
CLBK
$1.23B
| $254K | ﹤0.01% |
16,600
+2,023
| +14% | +$31.6K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.